Works matching IS 17407745 AND DT 2005 AND VI 2 AND IP 4
Results: 17
Panel discussion of case study 1.
- Published in:
- Clinical Trials, 2005, v. 2, n. 4, p. 319, doi. 10.1191/1740774505cn103oa
- By:
- Publication type:
- Article
Bayesian predictions of final outcomes: regulatory approval of a spinal implant.
- Published in:
- Clinical Trials, 2005, v. 2, n. 4, p. 325, doi. 10.1191/1740774505cn104oa
- By:
- Publication type:
- Article
Panel discussion of case study 2.
- Published in:
- Clinical Trials, 2005, v. 2, n. 4, p. 334, doi. 10.1191/1740774505cn105oa
- By:
- Publication type:
- Article
ASTIN: a Bayesian adaptive dose–response trial in acute stroke.
- Published in:
- Clinical Trials, 2005, v. 2, n. 4, p. 340, doi. 10.1191/1740774505cn094oa
- By:
- Publication type:
- Article
Panel discussion of case study 3.
- Published in:
- Clinical Trials, 2005, v. 2, n. 4, p. 352, doi. 10.1191/1740774505cn106oa
- By:
- Publication type:
- Article
The experience in the FDA's Center for Devices and Radiological Health with Bayesian strategies.
- Published in:
- Clinical Trials, 2005, v. 2, n. 4, p. 359, doi. 10.1191/1740774505cn093oa
- By:
- Publication type:
- Article
Statistical issues: a roundtable discussion.
- Published in:
- Clinical Trials, 2005, v. 2, n. 4, p. 364, doi. 10.1191/1740774505cn107oa
- By:
- Publication type:
- Article
FDA senior management perspectives.
- Published in:
- Clinical Trials, 2005, v. 2, n. 4, p. 373, doi. 10.1191/1740774505cn109oa
- By:
- Publication type:
- Article
Editorial.
- Published in:
- Clinical Trials, 2005, v. 2, n. 4, p. 271, doi. 10.1191/1740774505cn108ed
- By:
- Publication type:
- Article
FDA introductory comments: clinical studies design and evaluation issues.
- Published in:
- Clinical Trials, 2005, v. 2, n. 4, p. 273, doi. 10.1191/1740774505cn096oa
- By:
- Publication type:
- Article
How FDA currently makes decisions on clinical studies.
- Published in:
- Clinical Trials, 2005, v. 2, n. 4, p. 276, doi. 10.1191/1740774505cn097oa
- By:
- Publication type:
- Article
Introduction to Bayesian methods I: measuring the strength of evidence.
- Published in:
- Clinical Trials, 2005, v. 2, n. 4, p. 282, doi. 10.1191/1740774505cn098oa
- By:
- Publication type:
- Article
Introduction to Bayesian methods II: fundamental concepts.
- Published in:
- Clinical Trials, 2005, v. 2, n. 4, p. 291, doi. 10.1191/1740774505cn099oa
- By:
- Publication type:
- Article
Introduction to Bayesian methods III: use and interpretation of Bayesian tools in design and analysis.
- Published in:
- Clinical Trials, 2005, v. 2, n. 4, p. 295, doi. 10.1191/1740774505cn100oa
- By:
- Publication type:
- Article
Floor discussion.
- Published in:
- Clinical Trials, 2005, v. 2, n. 4, p. 301, doi. 10.1191/1740774505cn101oa
- By:
- Publication type:
- Article
A Bayesian approach to randomized controlled trials in children utilizing information from adults: the case of Guillain-Barré syndrome.
- Published in:
- Clinical Trials, 2005, v. 2, n. 4, p. 305, doi. 10.1191/1740774505cn102oa
- By:
- Publication type:
- Article
Using prior distributions to synthesize historical evidence: comments on the Goodman–Sladky case study of IVIg in Guillain–Barré syndrome.
- Published in:
- Clinical Trials, 2005, v. 2, n. 4, p. 311, doi. 10.1191/1740774505cn095oa
- By:
- Publication type:
- Article